Ashtead Group plc (LON:AHT – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 5,530.79 ($71.73) and traded as high as GBX 5,854 ($75.92). Ashtead Group shares last traded at GBX 5,820 ($75.48), with a volume of 297,598 shares.
Wall Street Analyst Weigh In
Several research analysts have recently commented on the company. Berenberg Bank reiterated a “buy” rating and set a GBX 7,000 ($90.78) target price on shares of Ashtead Group in a research note on Monday, October 14th. Jefferies Financial Group reiterated a “buy” rating and set a GBX 6,150 ($79.76) target price on shares of Ashtead Group in a research note on Tuesday, September 3rd. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 6,500 ($84.30) target price on shares of Ashtead Group in a research note on Wednesday, September 4th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Ashtead Group has an average rating of “Moderate Buy” and an average price target of GBX 5,537.86 ($71.82).
Read Our Latest Stock Report on Ashtead Group
Ashtead Group Price Performance
Insider Activity at Ashtead Group
In related news, insider Lucinda Riches sold 1,000 shares of the business’s stock in a transaction on Thursday, October 17th. The stock was sold at an average price of GBX 5,880 ($76.25), for a total value of £58,800 ($76,254.70). 0.64% of the stock is currently owned by corporate insiders.
Ashtead Group Company Profile
Ashtead Group plc, together with its subsidiaries, engages in the construction, industrial, and general equipment rental business in the United States, the United Kingdom, and Canada. It provides pumps, power generation, heating, cooling, scaffolding, traffic management, temporary flooring, trench shoring, and lifting services.
Featured Stories
- Five stocks we like better than Ashtead Group
- What is a Special Dividend?
- Intel: Is Now the Time to Be Brave?
- How to Invest in Biotech Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Ashtead Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashtead Group and related companies with MarketBeat.com's FREE daily email newsletter.